News und Analysen
3 Small-Cap Marijuana Stocks to Get on Your Radar
When it comes to the fastest-growing, and riskiest, industries in the stock market, none takes the cake like legal marijuana.According to cannabis research firm The Arcview Group, legal sales in....
ALPHA MOS : CHIFFRE D'AFFAIRES NEUF MOIS 2017
En M€ - Normes IFRS
Données non auditées
2017
2016
Variation
Chiffre d'affaires 1er semestre
2,1
3,9
-47%
Chiffre d'affaires 3ème....
The Double Whammy That Sent Marijuana Stock Insys Therapeutics Crashing as Much as 30%
Shares of Insys Therapeutics (NASDAQ: INSY), a small-cap biotech with a focus on pain management, plunged as much as 30% on Wednesday after receiving a double whammy. One whammy was the arrest of....
3 Companies Tackling the Antibiotic-Resistant Bacteria Crisis
Antibiotics have saved countless lives since they were discovered nearly 90 years ago. However, decades of overuse have caused some bacteria to evolve antibiotic resistance, which poses a huge....
Why DBV Technologies SA Plummeted and Aimmune Therapeutics Inc Skyrocketed Today
DBV Technologies (NASDAQ: DBVT) is down 45% at 12:48 p.m. EDT after announcing that its peanut allergy treatment, Viaskin Peanut, failed -- albeit not by much -- a phase 3 trial. The results....
This Marijuana Stock Could Be the Biggest Comeback Story of 2018
Insys Therapeutics (NASDAQ: INSY) is one of the most hated biotech stocks on the market today. That's the case, at least, if you use short interest as a proxy for how much investors hate a given....
Legalizing Recreational Marijuana in Colorado Reversed a 14-Year Trend of Rising Opioid-Related Deaths
The marijuana industry is, for lack of a better pun, sprouting like a weed. According to cannabis research firm ArcView, the North American legal weed market grew by 34% in 2016 and is expected to....
10 Stunning Numbers You Need to Know About Breast Cancer
October is breast cancer awareness month. Of course, for many American families, there's no need for a month to be designated to remember breast cancer. They're more than aware of the disease....
The Most Disappointing Marijuana Stock Plunged Once Again Last Week
The legal-marijuana industry is growing at an incredible pace, which is a big reason why investors seemingly can't get enough of pot stocks. According to Marijuana Business Daily's latest report,....
ALPHA MOS : INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS
INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS PREVUES PAR L'ARTICLE L. 233-8 II DU CODE DE COMMERCE ET L'ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AUTORITE DES MARCHES....
After Gaining 16% Early Last Week, This Marijuana Stock Quickly Kissed It All Goodbye
Few industries, if any, offer the type of growth that legal cannabis can bring to the table, which is a big reason why investors have flocked to marijuana stocks in droves. Many of the largest pot....
This Company Gained 76% in its IPO -- and It Isn't Even a Tech Company
In a sure sign that the biotech bull market is alive and well, Rhythm Pharmaceuticals (NASDAQ: RYTM) raised almost $120 million at $17 per share in its initial public offering on Thursday. In its....
What's Behind Celldex Therapeutics, Inc.'s 16% Rally in September?
Shares of Celldex Therapeutics, Inc. (NASDAQ: CLDX), a clinical-stage biotech, rose 16.3% in September, according to data from S&P Global Market Intelligence. It looks like investors....
This U.S. Marijuana Stock Is Arguably the Best on the Market -- and It's Dirt Cheap
What's the best U.S. marijuana stock on the market right now?Including only the U.S. in the question excludes several of the top candidates, such as U.K.-based GW Pharmaceuticals (NASDAQ: GWPH)....
ALPHA MOS : INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE
INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS PREVUES PAR L'ARTICLE L. 233-8 II DU CODE DE COMMERCE ET L'ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AUTORITE DES MARCHES....
Why Celldex Therapeutics, Inc. Jumped Higher Today
Celldex Therapeutics (NASDAQ: CLDX) closed on Monday up 12.8%, with no apparent news to justify the double-digit gain by the biotech company.The move follows an 8.1% jump on Friday. Sometimes,....
This Marijuana Stock Is On an 8-Day Losing Streak -- Is It Time to Buy?
Over the trailing year, there's arguably been no better-performing industry than marijuana and marijuana stocks. A majority of pot stocks have moved significantly higher over the past year, with a....
ALPHA MOS : COMMUNIQUE DE MISE A DISPOSITION DE LA NOTE EN REPONSE
OFFRE PUBLIQUE D'ACHAT SIMPLIFIEE
VISANT LES ACTIONS DE LA SOCIETE
ALPHA MOS
INITIEE CONJOINTEMENT PAR
JOLT CAPITAL
AMBROSIA INVESTMENTS
PRESENTEE PAR
ALANTRA
COMMUNIQUE DE MISE....
Here's Why Nabriva Therapeutics PLC Is Soaring Today
For the second day in a row, investors in Nabriva Therapeutics (NASDAQ: NBRV) are enjoying double-digit gains. Shares of the clinical-stage biotech are up 15% as of 11:30 a.m. EDT on Tuesday. The....
Of the 14 Largest Marijuana Stocks, Only These 2 Are Down Over the Past Year
The stock market has been on a tear since hitting a trough in March 2009, but in recent years it's marijuana stocks that have headed to the front of the class, so to speak. Back in June, we looked....
ALPHA MOS : RESULTATS SEMESTRIELS 2017
Au cours de sa réunion du 11 septembre 2017, le Conseil d'administration d'Alpha MOS (Euronext Paris - Compartiment C - Code ISIN : FR0000062804-ALM) a arrêté les comptes semestriels 2017,....
ALPHA MOS : MISE A DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL 2017
Alpha MOS (Euronext Paris - Compartiment C - Code ISIN : FR0000062804-ALM) annonce, ce jour, avoir mis à la disposition du public et déposé auprès de l'Autorité des marchés financiers (AMF)....
ALPHA MOS : MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES A L'ASSEMBLEE GENERALE MIXTE DU 29 SEPTEMBRE 2017
Les actionnaires de la société Alpha MOS sont invités à participer à une assemblée générale mixte qui se tiendra le 29 septembre 2017 à 10 heures.
Au siège social de la société :
Immeuble Le....
Why This Marijuana Stock Crashed 18.5% in August
Arizona's attorney general is suing Insys Therapeutics (NASDAQ: INSY) over its marketing of the fentanyl opioid spray, Subsys, and that news caused the company's shares to tumble 18.5% in August,....
94% of Americans Support Legalizing Medical Marijuana, but Not Congress
When it comes to the fastest, most consistently growing industries in the U.S. right now, legal marijuana is near the top of the list. Investment firm Cowen & Co. has predicted that U.S. legal....